• vcard
D 615.259.1527
F 615.259.1573
  • Education
    • M.B.A., University of Tennessee, 2001, Finance, New Ventures; Finance Dept. Torch Fund Portfolio Manager; John C. Cox, Sr. MBA Fellowship
    • J.D., University of Tennessee College of Law, 2001, Business Transactions; Contributor to Transactions: Tennessee Business Law Journal; Sports and Entertainment Law Society
    • B.A., magna cum laude, Lipscomb University, 1994, History Education
Kolin Holladay is keenly aware of the impact legal advice can have on the entirety of a client’s business. As a previous small business owner himself, Kolin has first-hand insight into the steps involved with business acquisitions, as well as selling a business to strategic partners. He brings a broad perspective to clients’ business operations and strategic plans.
 
Due to his personal business experience and practical legal approach, clients often view Kolin as a trusted advisor. He typically serves as outside general counsel to middle-market companies, but enjoys working with companies of all sizes – from startups to multi-national corporations.
 
Some of the industries in which Kolin has experience include health care, entertainment, service, technology, consumer products, retail, finance, and restaurant sectors. His practice areas focus on the following transaction types: 
  • Mergers and acquisitions 
  • Securities offerings and capital formation 
  • Advising corporate boards 
  • Contract negotiation and interpretation
  • Represented seller in a $66 million business divestiture in the pharmaceutical industry
  • Represented seller in a $38 million business divestiture in the fabrication industry
  • Represented purchaser in $25 million strategic stock acquisition in the agri-business industry
  • Represented purchaser in a $510 million drilling rig division acquisition
  • Represented transportation industry borrower in $225 million senior lending credit facility
  • Represented purchaser in a $120 million strategic acquisition in the biotech and household cleaning industries
  • Represented issuer on an initial public offering of common stock in the pharmaceutical industry
  • Represented purchaser in strategic purchase of FDA-approved drug
  • Represented insurance industry seller in a business divestiture
  • Represented issuer in a private offering of preferred stock in energy, brewing, and pharmaceutical industries